StockNews.AI
CCRN
StockNews.AI
167 days

Cross Country Healthcare Announces Fourth Quarter and Full Year 2024 Financial Results

1. Cross Country Healthcare reported a 25% decrease in Q4 2024 revenue. 2. The company's full-year 2024 revenue fell by 33% compared to 2023.

-6.29%Current Return
VS
-1.77%S&P 500
$16.8603/05 04:21 PM EDTEvent Start

$15.803/06 10:48 PM EDTLatest Updated
2m saved
Insight
Article

FAQ

Why Very Bearish?

A 25% decline in quarterly revenue and a 33% annual reduction signals severe financial distress, reminiscent of downturns prior to company restructurings. This could lead to diminished investor confidence and subsequent price drops.

How important is it?

The substantial revenue decline directly affects CCRN’s financial stability and market position, making it highly significant for investors and analysts.

Why Short Term?

Immediate impacts are expected due to revenue drops; similar past examples saw rapid reactions in stock prices following negative earnings reports.

Related Companies

BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (the “Company”) (Nasdaq: CCRN) today announced financial results for its fourth quarter and full year ended December 31, 2024. SELECTED FINANCIAL INFORMATION: Dollars are in thousands, except per share amounts Q4 2024 Variance Q4 2024 vs Q4 2023 Variance Q4 2024 vs Q3 2024 Full Year 2024   Variance 2024 vs 2023 Revenue $ 309,940       (25 ) %   (2 ) % $ 1,344,004       (33 ) % Gross profit margin*   20.0   %   (190 ) bps   (40 ).

Related News